Wang Jin, Yu Ye
Department of Pharmacology and Chemical Biology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
College of Bioscience and Biotechnology, Hu-nan Agricultural University, Changsha 410128, China.
Acta Pharmacol Sin. 2016 Jan;37(1):44-55. doi: 10.1038/aps.2015.127.
P2X receptors, as ATP-gated non-selective trimeric ion channels, are permeable to Na(+), K(+) and Ca(2+). Comparing with other ligand-gated ion channel families, P2X receptors are distinct in their unique gating properties and pathophysiological roles, and have attracted attention as promising drug targets for a variety of diseases, such as neuropathic pain, multiple sclerosis, rheumatoid arthritis and thrombus. Several small molecule inhibitors for distinct P2X subtypes have entered into clinical trials. However, many questions regarding the gating mechanism of P2X remain unsolved. The structural determinations of P2X receptors at the resting and ATP-bound open states revealed that P2X receptor gating is a cooperative allosteric process involving multiple domains, which marks the beginning of the post-structure era of P2X research at atomic level. Here, we review the current knowledge on the structure-function relationship of P2X receptors, depict the whole picture of allosteric changes during the channel gating, and summarize the active sites that may contribute to new strategies for developing novel allosteric drugs targeting P2X receptors.
P2X受体作为ATP门控的非选择性三聚体离子通道,对Na(+)、K(+)和Ca(2+)具有通透性。与其他配体门控离子通道家族相比,P2X受体在其独特的门控特性和病理生理作用方面具有独特性,并作为多种疾病(如神经性疼痛、多发性硬化症、类风湿性关节炎和血栓)的有前景的药物靶点而受到关注。几种针对不同P2X亚型的小分子抑制剂已进入临床试验。然而,关于P2X门控机制的许多问题仍未解决。P2X受体在静息态和ATP结合开放态的结构测定表明,P2X受体门控是一个涉及多个结构域的协同变构过程,这标志着P2X在原子水平研究的后结构时代的开始。在这里,我们综述了关于P2X受体结构-功能关系的当前知识,描绘了通道门控过程中变构变化的全貌,并总结了可能有助于开发针对P2X受体的新型变构药物新策略的活性位点。